Aprea Therapeutics, Inc.
APRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,959 | -$14,287 | -$112,662 | -$37,127 |
| Dep. & Amort. | $22 | $7 | $186 | $272 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $489 | $444 | $16,981 | $7,814 |
| Change in WC | -$1,055 | $1,619 | -$1,759 | -$8,327 |
| Other Non-Cash | -$54 | $39 | $72,242 | -$317 |
| Operating Cash Flow | -$13,557 | -$12,178 | -$25,011 | -$37,686 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | -$93 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$15 | -$93 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $16,140 | $5,789 | $683 | $1,539 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,318 | -$649 | $0 | $208 |
| Financing Cash Flow | $14,822 | $5,140 | $683 | $1,747 |
| Forex Effect | -$7 | -$8 | $39 | -$2 |
| Net Chg. in Cash | $1,243 | -$7,139 | -$24,289 | -$35,942 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,648 | $28,787 | $53,076 | $89,018 |
| End Cash | $22,890 | $21,648 | $28,787 | $53,076 |
| Free Cash Flow | -$13,572 | -$12,271 | -$25,011 | -$37,686 |